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The World Heal Organization (WHO) has identified malaria diag-
nosis as being pivotal to eradicating the disease by 2030 as
stipulated in the Sustainable Development Goals (SDG). The data
presented here was obtained from outpatients of a hospital in the
South Western Region of Nigeria from November 2016 to May
2017. The data contains malaria incidence amongst asymptomatic
and symptomatic outpatients in the period under review. Malaria
incidence was obtained using two diagnostic test kits, Bioline SD
(HRP-2) and ACON (HRP-2/Aldolase) alongside Microscopy as gold
standard. Specificity, Sensitivity and Kappa statistic of each test
device is presented in the tables herewith. Data presented here
could be used alongside other data sources to assess the state of
malaria diagnostics.
& 2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
versity.edu.ng (G.I. Olasehinde).
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Table 1
Incidence of P. falciparum using Bioline
Age group in years No of samp
Male
0–5 35
6–11 10
12–17 6
18–23 8
24–29 12
30 17
Total (%) 88 (44)ubject area Microbiology, Parasitology
ore specific subject area Malaria Diagnosis and Control
ype of data Table
ow data was acquired Microscopy; Rapid Diagnostic Methods
ata format Raw, Analyzed data in tables
xperimental factors Ethical approval obtained from BIOSREC, Consent and accent sought
xperimental features Blood samples obtained from febrile and non-febrile subjects visiting
the selected health centers and tested for malaria using different
methodsata source location Ado Odo/Ota, Ogun State, Nigeria
ata accessibility Data is available in article
elated research article Dozie and Chukwuocha [4] Comparative Evaluation of Malaria Rapid
Diagnostic Test Kits Commercially Available in Parts of South Eastern
Nigeria J Trop Dis 04(02) [4]Value of the data
 Data provided here could inform the quality and choice of Rapid Diagnostic Test (RDT) in malaria
endemic regions.
 Data presented here, when compared with data from other regions, could be used to measure the
efficacy of RDTs vis-à-vis the malaria control agenda.
 Data provided may inform the development of cheap and non-invasive diagnostic method for
malaria.1. Data
Tables 1–4 present data from diagnosis using the RDT kits as well as microscopy among asymp-
tomatic participants. The tables contain the counts for total number of participants alongside the
number that tested positive. Tables 5–8 present results obtained for the RDTs and microscopy among
participants who were symptomatic i.e. had a fever Z 37.5 °C. Tables 9–12 contains a summary
assessment of both RDT kits tested, using microscopy as baseline).SD kits among asymptomatic carriers.
les collected No of positive samples on kit (BIOLINE SD)
Female Total Male Female Total
43 78 9 13 22
9 19 2 1 3
11 17 – 3 3
12 20 1 1 2
19 31 – 2 2
18 35 1 1 2
112 (66) 200 (100) 13 (6.5) 21 (10.5) 34 (17)
Table 2
Incidence of P. falciparum using ACON kits among asymptomatic carriers.
Age group in years No of samples collected No of positive samples in kit (ACON)
Male Female Total Male female Total
0–5 35 43 78 6 8 14
6–11 10 9 19 3 3 6
12–17 6 11 17 – 4 4
18–23 8 12 20 2 2 4
24–29 12 19 31 1 4 5
30 17 18 35 – 3 3
Total (%) 88 (44) 112 (66) 200 (100) 12 (6) 24(12) 36(18)
Table 3
Incidence of P. falciparum using microscopic method among asymptomatic carriers.
No of samples collected No of positive samples
Male Female Total Male Female Total
0–5 35 43 78 12 16 28
6–11 10 9 19 2 3 5
12–17 6 11 17 4 3 7
18–23 8 12 20 3 4 7
24–29 12 19 31 – 4 4
30 17 18 35 1 1 2
Total (%) 88 (44) 112 (66) 200 (100) 22 (11) 31 (15.5) 53 (26.5)
Table 4
Comparative incidence rates of malaria among asymptomatic subjects using ACON, Bioline SD kits and microscopy.
Sex Number of sample collected (%) Number of Positive samples (%)
Microscopy Bioline SD ACON
Male 88 (44) 22 (25) 13 (14.8) 12(13.6)
Female 112 (56) 31 (27.7) 21 (18.8) 24(21.4)
Total 200 (100) 53 (26.5) 34 (17) 36(18)
Table 5
Incidence of P. falciparum and P. vivax using ACON RDT kit among symptomatic subjects.
Age group in years Number of samples collected Number of positive samples
Male Female Total
Male Female Total P.f P.v P.f P.v P.f P.v
0–5 1 – 1 – – – – – –
6–10 1 1 2 1 – – – 1 –
11–15 – 4 4 1 – – – 1 –
16–20 11 16 27 7 2 9 – 16 2
21–25 3 4 7 2 – 1 – 3 –
426 9 10 19 – – 2 – 2 –
Total 25 (41.7) 35 (58.3) 60 (100) 11 (47.8) 2(100) 12(52.2) -(-) 23(100) 2(100)
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Table 6
Incidence of P. falciparum using Bioline SD kits among symptomatic subjects.
Age
group in
years
Number of samples collected Number of positive samples
Male Female Total Male Female Total
0–5 1 – 1 – – –
6–10 1 1 2 1 – 1
11–15 – 4 4 1 1 2
16–20 11 16 27 7 9 16
21–25 3 4 7 2 1 3
426 9 10 19 – 2 2
Total 25(41.7) 35(58.3) 60(100) 11 (45.8) 13(54.2) 24(100)
Table 7
Incidence of P. falciparum and P. vivax using microscopy among symptomatic subjects.
Age group in years Number of samples collected Number of Positive samples
Male Female Total Male Female Total
0–5 1 – 1 1 – 1
6–10 1 1 2 1 – 1
11–15 – 4 4 – – –
16–20 11 16 27 10 9 19
21–25 3 4 7 – – –
426 9 10 19 4 – 4
Total 25(41.7) 35(58.3) 60 (100) 16(64) 9 (36) 25 (100)
Table 8
Incidence of malaria using ACON kits, Bioline SD kits and microscopy among symptomatic subjects.
Sex Number of samples collected (%) Number of Positive Samples (%)
Microscopy (%) RDTs
ACON Bioline SD (HRP-2) (%)
HRP-2 (%) Pan-Aldolase (%)
Male 25 (41.7) 16 (64) 11 (44) 2 (8) 11 (44)
Female 35 (58.3) 9 (25.7) 12 (34.3) – 13 (37.1)
Total 60 (100) 25 (41.7) 23(38) 2 (3.3) 24 (40)
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Data was obtained between November, 2016 and May, 2017 from 260 participants, 200 asymp-
tomatic and 60 symptomatic subjects attending the University Health Centre.
Blood samples for analysis were obtained using either of two methods; direct sampling via finger
prick or venous blood collected into EDTA bottles. Tests were performed using two RDT kits
(ACON Malaria P.f/ Pan Rapid Test Device and SD BIOLINE Malaria Ag P.f test kits) [1-5]. Thick blood
smears were prepared and stained with 10% Giemsa for 15min to determine parasitemia which was
estimated from the thick film by counting the number of parasites within 200 white blood cells
(leukocyte) [6,7].
Table 9
Performance of microscopy and RDTs across both cohorts.
Symptomatic Cohort N¼60 Asymptomatic Cohort N¼200
Positive Negative Prevalence Sensitivity (95% CI) Fishers P value κ value Positive Negative Prevalence Sensitivity (95% CI) Fishers P value κ value
SD Bioline 24 36 40% 96% (0.7965–0.990) o0.0001 0.966 34 166 64.15% 64.15% (0.4980–0.7686) o0.0001 0.725
ACON 25 35 41.67% 100% (0.8628–1.000) o0.0001 1.000 36 164 18% 67.92% (0.5368–0.8008) o0.0001 0.757
Microscopy 25 35 41.67% 53 147 26.5%
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Table 10
Test specifications.
RDT Specification
ACON Malaria Pf/Pan test kit HRP-2 antigen
Aldolase antigen
SD Bioline Malaria Ag Pf test Kit HRP-2 Antigen
Table 11
Contingency tables for symptomatic cohort.
Microscopy
SD Bioline Kit Positive Negative
Positive 19 5
Negative 6 30
Microscopy
ACON Malaria Pf/Pan Kit Positive Negative
Positive 21 4
Negative 4 31
Table 12
Contingency tables for asymptomatic cohort.
Microscopy
SD Bioline Kit Positive Negative
Positive 34 0
Negative 19 147
Microscopy
ACON Malaria Pf/Pan Kit Positive Negative
Positive 33 3
Negative 20 144
G.I. Olasehinde et al. / Data in Brief 20 (2018) 503–509508The two-tailed Fisher's exact test (95% Confidence Interval) was used to check for significant
differences in the sensitivities of the RDTs. Inter-test agreement for positive and negative results was
expressed by the percentage of overall agreement. Kappa statistic (κ) was used to determine the
agreement between malaria RDTs and the reference methods. κ-values 0.6–0.8 was considered as
good while k-values 40.8 were considered excellent.Acknowledgments
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